Article
Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatment.
BMC gastroenterology - 16 Apr 2010
Ogawa Eiichi, Furusyo Norihiro, Toyoda Kazuhiro, Taniai Hiroaki, Otaguro Shigeru, Kainuma Mosaburo, Murata Masayuki, Sawayama Yasunori, Hayashi Jun
Abstract excerpt
BACKGROUND: An early virological response (EVR) after the start of interferon (IFN) treatment for chronic hepatitis C leads to a successful virological outcome. To analyze an association between sustained virological response (SVR) and EVR by comparing TaqMan with Amplicor assays in HCV genotype 1-infected patients treated with pegylated (PEG)-IFN alpha-2b plus ribavirin (RBV). METHODS: We retrospectively...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
